Correction to "Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease".
De Simone A, La Pietra V, Betari N, Petragnani N, Conte M, Daniele S, Pietrobono D, Martini C, Petralla S, Casadei R, Davani L, Frabetti F, Russomanno P, Novellino E, Montanari S, Tumiatti V, Ballerini P, Sarno F, Nebbioso A, Altucci L, Monti B, Andrisano V, Milelli A.
De Simone A, et al. Among authors: milelli a.
ACS Med Chem Lett. 2019 Aug 6;10(9):1357. doi: 10.1021/acsmedchemlett.9b00316. eCollection 2019 Sep 12.
ACS Med Chem Lett. 2019.
PMID: 31531210
Free PMC article.